Illinois Governor JB Pritzker on Monday announced that AbbVie in Lake County will be investing $380 million to construct two new manufacturing facilities, creating 300 new jobs.
Pritzker, the Illinois Department of Commerce and Economic Opportunity and the Illinois Economic Development Corporation made the announcement Monday morning.
AbbVie will construct two new active pharmaceutical ingredient (API) manufacturing facilities at its North Chicago location.
The company will be investing $380 million in the project, which will create 300 new full-time jobs.
The governor’s office said the new investment underscores Illinois’ “robust and rapidly expanding” life sciences ecosystem, supported by a skilled workforce, robust infrastructure and a strong manufacturing sector.
“AbbVie’s significant investment fortifies Illinois’ position as a global biomanufacturing leader while creating hundreds of new jobs,” Pritzker said.
“With our world-class workforce, modern infrastructure, strategic location, and cutting-edge research ecosystem, this expansion underscores why Illinois is the best place to grow and innovate. Together, we’re advancing pharmaceutical manufacturing and R&D and building a stronger economic future for communities across Illinois,” the governor said.
The governor’s office said AbbVie’s investment shows Illinois is continuing to strengthen its position as a global hub for both life sciences and advanced manufacturing.
“This milestone demonstrates further progress against AbbVie’s $100 billion commitment to U.S. R&D and capital investments over the next decade,” AbbVie Chairman and CEO Robert Michael said.
“By strengthening AbbVie’s U.S. manufacturing capabilities, we are well-positioned to support our investment in innovation and enhance our ability to deliver next-generation medicines to patients,” Michael said.
The project includes the construction of two state-of-the-art new facilities to support the production of next-generation neuroscience and obesity-reduction medicines.
AbbVie has announced plans to invest $575 million in North Chicago over the past six months, which includes a previously announced $195 million investment to construct a new chemical synthesis API manufacturing facility and add 50 full-time jobs.
“By leveraging our economic development tools, the State of Illinois is supporting AbbVie in their efforts to expand advanced manufacturing, create hundreds of quality jobs, and keep Illinois at the forefront of innovation in next-generation medicines,” Illinois Department of Commerce and Economic Opportunity Director Kristin Richards said.
AbbVie has committed to creating at least 350 new full-time jobs in Illinois, where it is headquartered and employs more than 11,500 people, as part of the Economic Development for a Growing Economy (EDGE) agreement with the state.
State officials said companies in the EDGE program in 2025 committed to more than $2.6 billion in investments in communities across the state.
“AbbVie’s expansion in Illinois reinforces our state’s standing as a global life sciences leader,” Illinois EDC President and CEO Christy George said.
“From world-class research institutions and a highly skilled workforce to a deeply integrated manufacturing and logistics network, Illinois offers the full ecosystem required for biopharmaceutical innovation. We are proud that AbbVie continues to grow its legacy here, advancing breakthrough medicines and creating high-quality jobs that strengthen communities across our state,” George said.